Skip to contentE
Encompass Health Corp
E
EHCEncompass Health Corp Q2 2026 · 10-Q
Revenue$1.60B$1.60B+9.6% vs Q2 2025 Net Income$153.90M$153.90M+8.3% vs Q2 2025 EPS Diluted$1.54$1.54+10.8% vs Q2 2025 Operating Cash Flowderived$282,600,000+4.6% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Encompass Health Corp · CIK 785161 · Engraved from SEC EDGAR
Free Cash Flowderived$62,300,000−45.0% Margins · derivedNet margin9.6%−0.1 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 7, 2026 · 38 d after period end